SEC Filings - Supernus Pharmaceuticals

Filing date	Description	Form	Filing Group	View
March 1, 2021	Notification that form 10-K will be submitted late	NT 10-K	Annual Filings	View HTML 0001356576-21-000021.pdf 0001356576-21-000021.xls
February 26, 2021	Report of unscheduled material events or corporate event	8-K	Current Reports	View HTML 0001356576-21-000016.pdf 0001356576-21-000016.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
February 24, 2021	Report of unscheduled material events or corporate event	8-K	Current Reports	View HTML 0001356576-21-000010.pdf 0001356576-21-000010.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
February 24, 2021	Report of unscheduled material events or corporate event	8-K	Current Reports	View HTML 0001356576-21-000013.pdf 0001356576-21-000013.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
February 23, 2021	Statement of changes in beneficial ownership of securities	4	3,4,5	View HTML 0001104659-21-026926.pdf 0001104659-21-026926.xls
February 23, 2021	Statement of changes in beneficial ownership of securities	4	3,4,5	View HTML 0001104659-21-026927.pdf 0001104659-21-026927.xls
February 23, 2021	Statement of changes in beneficial ownership of securities	4	3,4,5	View HTML 0001104659-21-026928.pdf 0001104659-21-026928.xls
February 23, 2021	Statement of changes in beneficial ownership of securities	4	3,4,5	View HTML 0001104659-21-026929.pdf 0001104659-21-026929.xls
February 23, 2021	Statement of changes in beneficial ownership of securities	4	3,4,5	View HTML 0001104659-21-026931.pdf 0001104659-21-026931.xls
February 23, 2021	Statement of changes in beneficial ownership of securities	4	3,4,5	View HTML 0001104659-21-026930.pdf 0001104659-21-026930.xls

Data provided by Kaleidoscope.